Observational, Postmarketing Surveillance Study of Spinraza Injection (Nusinersen Sodium)

Clinical trial NCT04317794 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04317794
Sponsor: Biogen
Status: ACTIVE_NOT_RECRUITING
Study type: OBSERVATIONAL

Muscular Atrophy, Spinal

Start date: 2019-07-02
Primary completion: 2027-02-05
Enrollment: 74

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.